LRRFIP1 and glioblastoma: The involvement of miRNAs in GBM cell resistance to chemotherapy was first reported by Li et al. [52]; they showed that oncomiR-21 is involved in GBM cell resistance to the chemotherapeutic agent teniposide by targeting LRR binding FLII interacting protein 1 (LRRFIP1) mRNA.